Alexion Biopharmaceutical Fellowships

Alexion, in collaboration with MCPHS University, is pleased to offer two unique PharmD Fellowship Programs to expose qualified Doctor of Pharmacy graduates to the biopharmaceutical industry, and enhance and promote the role of pharmacists within the biopharmaceutical industry. The two Fellowship Programs are in Global Medical Information and Global Medical Affairs.

These two-year fellowships offer an opportunity to gain extensive experience within global medical information and global medical affairs at a fast-paced, exciting, innovative, patient centric, global biopharmaceutical company focused on developing and delivering life transforming therapies for patients with devastating and rare diseases.

Global Medical Information Fellowship Overview

Background: The primary responsibility of the Alexion Global Medical Information team is to respond to unsolicited requests for medical and clinical information about Alexion’s marketed products and products in development received from healthcare professionals, patients/consumers, and public/private payers.

Program Overview: The Alexion Global Medical Information Fellowship will give the fellow the opportunity to learn:

  • The core function of global medical information
  • Laws, regulations, regulatory guidances governing the medical information function
  • Drug development, particularly the development of biologics in the orphan drug/rare disease space
  • Laws, regulations, and regulatory guidances governing marketing and promotion
  • Role and functions of different field-based teams (sales representatives, medical science liaisons, medical affairs managers, etc.)
  • Compassionate use and clinical development

The Alexion Global Medical Information Fellowship will provide the fellow the opportunity to further develop communications skills (both verbal and written), to develop project management skills, to increase understanding of drug development, and to learn about the rare diseases and therapeutic areas in which Alexion is focused on developing treatments. These areas include: Hypophosphatasia (HPP), Lysosomal Acid Lipase Deficiency (LAL-D), atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH), Molybdenum Cofactor Deficiency (MoCD), Neuromyelitis Optica (NMO), Delayed Graft Function (DGF), Gastrointestinal Graft-versus-Host Disease (GI GVHD), Mucopolysaccharidoses IIIB (MPS IIIB), Antibody Mediated Rejection (AMR), Myasthenia Gravis (MG), Antiphospholipid Syndrome (APS), Neurofibromatosis Type 1 (NF1), Crigler-Najjar Syndrome (CN-1), and Generalized Arterial Calcification of Infancy (GACI). Visit the research and development page at to learn more about Alexion’s current pipeline.

This two-year fellowship program will be based out of Alexion’s Global Headquarters in New Haven, CT. Please see our brochure for additional details.

Global Medical Affairs Fellowship Overview

Background: Health Care practitioners, regulators, payers and other customers are demanding sophisticated clinical and health-outcomes data and analyses to support the approval, reimbursement and prescription of new medicines. We must reorient our thinking along the lines of value delivered, articulating value propositions that are appropriate and relevant to right customers, and proactively impact the environment from early stage gates and throughout the product’s lifecycle.

Program Overview: The primary responsibility of the Alexion Global Medical Affairs team is to develop the Global Medical Affairs strategic plan, namely evidence generation (phase IIIB/IV studies), scientific communications, and scientific engagement.

The Alexion Global Medical Affairs Fellowship will give the fellow the opportunity to learn:

  • How to develop an Asset Global Medical Affairs Plan (MAP) and integrated evidence and scientific communication Plan under the direction of the Global Medical Affairs Leader (GMAL).
  • Develop capabilities on how to implement designated elements of the above-country MAP e.g. preparation for advisory boards; symposia in full compliance with scientific engagement standards and regulations.
  • Learn how to provide insightful medical/scientific input to brand campaigns and launches.
  • Support in the development of promotional, non-promotional and training materials in accordance with codes/ regulations.
  • Learn how to identify data gaps and design appropriate studies to support those data gaps in partnership with commercial and development colleagues, including:
    • Supporting the Integrated Global Medical Affairs team
    • Learn how to review Investigator Sponsored Research (ISRs) proposals to assess their strategic value based on scientific merit and strategic need;
    • Developing assigned research
  • Supporting excellence in external engagement with key stakeholders (HCPs, Patients, Payers and Regulators) to gain a deep understanding of customer needs.

The Alexion Global Medical Affairs Fellowship will provide the fellow the opportunity to further develop core medical competencies namely

  1. scientific and technical expertise;
  2. medical and value access;
  3. executional and operational excellence; and
  4. engagement skills (both verbal and written).

This two-year fellowship program will be based out of Alexion’s Global Headquarters in New Haven, CT.

About Alexion

Alexion is a global biopharmaceutical company focused on developing and delivering life transforming therapies for patients with devastating and rare diseases. Patients with these life-threatening diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.

As we continue to expand our operations to serve more patients in additional countries, Alexion has emerged as one of the world’s leading rare disease companies. Today, Alexion is advancing the most robust rare disease pipeline in the biotech industry, which, in addition to our complement and metabolic clinical programs, includes more than 30 diverse preclinical programs across a range of therapeutic modalities.

Alexion was established in the U.S. in 1992 and became a public company in 1996 (NASDAQ: ALXN). We were added to the NASDAQ-100 Index in 2011 and to the Standard & Poor's 500 Index in 2012.

Our global headquarters and research operations are in New Haven, CT. Alexion's approximately 3,000 employees around the world serve patients in 50 countries.

MCPHS University

MCPHS University provides an academic environment to guide and support fellows toward a successful career in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS University offers programs that embody scholarship, professional service, and community outreach.

Through MCPHS University, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS University faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.

As an adjunct assistant professor at MCPHS, the fellow may have the opportunity to:

  • Develop, coordinate, and teach courses
  • Co-precept pharmacy students on advanced experiential rotations
  • Create and publish scholarly research and/or review articles
  • Present research at scientific and clinical meetings
  • Participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs

Certificate of Completion

MCPHS University and Alexion will award a professional certificate upon successful completion of the fellowship program.


  • Fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
  • Applicants must have a Doctor of Pharmacy degree from an Accreditation Council for Pharmacy Education (ACPE) accredited college of pharmacy.
  • Candidates must have strong written and verbal communication skills and an interest in pursuing a career in the biopharmaceutical industry.
  • All candidates must have authorization to work in the United States throughout the duration of the two-year fellowship. No visa sponsorship will be provided.

Application Procedure

Participation in the American Society of Health-Systems Pharmacist (ASHP) Midyear Clinical Meeting Personnel Placement Service (PPS) is strongly encouraged, but not required. Candidates are encouraged to request a preliminary interview at the ASHP midyear meeting through the PPS website.

The formal application materials below must be received by December 20th. Submit via the online portal:

  • Letter of intent
  • Updated CV
  • Names and contact information of three references
  • Unofficial college transcript

Three letters of recommendations must be submitted directly from their authors upon request.

For more information, please contact the Fellowship Program Directors or our current fellow:

Global Medical Information
Michael J. DeLuca, PharmD, MBA, MSRA
Director, Medical Information – Metabolic Disorders

David Tao, PharmD
Fellow, Global Medical Information

Global Medical Affairs
Hugo Gomes da Silva, MD, MsC
Vice-President, Global Medical lead